{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:01:09Z","timestamp":1793221269361,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The implantable cardioverter-defibrillator (ICD) is a life-saving therapy in patients with hypertrophic cardiomyopathy (HCM) at risk of sudden cardiac death. Implantable cardioverter-defibrillator complications are of concern. The subcutaneous ICD (S-ICD) does not use transvenous leads and is expected to reduce complications. However, it does not provide bradycardia and anti-tachycardia pacing (ATP). The aim of this study was to compare appropriate and inappropriate ICD interventions, complications, disease-related adverse events and mortality between HCM patients implanted with a S- or transvenous (TV)-ICD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Consecutive HCM patients implanted with a S- (n = 216) or TV-ICD (n = 211) were enrolled. Propensity-adjusted cumulative Kaplan\u2013Meier curves and multivariate Cox proportional hazard ratios were used to compare 5-year event-free survival and the risk of events. The S-ICD patients had lower 5-year risk of appropriate (HR: 0.32; 95%CI: 0.15\u20130.65; P = 0.002) and inappropriate (HR: 0.44; 95%CI: 0.20\u20130.95; P = 0.038) ICD interventions, driven by a high incidence of ATP therapy in the TV-ICD group. The S- and TV-ICD patients experienced similar 5-year rate of device-related complications, albeit the risk of major lead-related complications was lower in S-ICD patients (HR: 0.17; 95%CI: 0.038\u20130.79; P = 0.023). The TV- and S-ICD patients displayed similar risk of disease-related complications (HR: 0.64; 95%CI: 0.27\u20131.52; P = 0.309) and mortality (HR: 0.74; 95%CI: 0.29\u20131.87; P = 0.521).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Hypertrophic cardiomyopathy patients implanted with a S-ICD had lower 5-year risk of appropriate and inappropriate ICD therapies as well as of major lead-related complications as compared to those implanted with a TV-ICD. Long-term comparative follow-up studies will clarify whether the lower incidence of major lead-related complications will translate into a morbidity or survival benefit.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/europace\/euad270","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T10:01:03Z","timestamp":1695117663000},"source":"Crossref","is-referenced-by-count":18,"title":["Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0306-7764","authenticated-orcid":false,"given":"Pietro","family":"Francia","sequence":"first","affiliation":[{"name":"Cardiology, Department of Clinical and Molecular Medicine, Sant\u2019Andrea Hospital , University Sapienza, Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3617-2739","authenticated-orcid":false,"given":"Matteo","family":"Ziacchi","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Policlinico S.Orsola-Malpighi , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4204-4365","authenticated-orcid":false,"given":"Carmen","family":"Adduci","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Clinical and Molecular Medicine, Sant\u2019Andrea Hospital , University Sapienza, Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Ammendola","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \u2018Luigi Vanvitelli\u2019, Monaldi Hospital , Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4594-2240","authenticated-orcid":false,"given":"Paolo","family":"Pieragnoli","sequence":"additional","affiliation":[{"name":"Careggi University Hospital, University of Florence , Florence , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1144-5000","authenticated-orcid":false,"given":"Paolo","family":"De Filippo","sequence":"additional","affiliation":[{"name":"Papa Giovanni XXIII Hospital , Bergamo , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4739-7004","authenticated-orcid":false,"given":"Antonio","family":"Rapacciuolo","sequence":"additional","affiliation":[{"name":"Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-3649","authenticated-orcid":false,"given":"Valeria","family":"Rella","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Neural and Metabolic Sciences, IRCCS, Istituto Auxologico Italiano, San Luca Hospital , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8574-9421","authenticated-orcid":false,"given":"Federico","family":"Migliore","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic Vascular Sciences and Public Health University of Padova , Padova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8240-9181","authenticated-orcid":false,"given":"Stefano","family":"Viani","sequence":"additional","affiliation":[{"name":"Second Cardiology Division, Cardio-Thoracic and Vascular Department, University Hospital of Pisa , Pisa , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Beatrice","family":"Musumeci","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Clinical and Molecular Medicine, Sant\u2019Andrea Hospital , University Sapienza, Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0295-0440","authenticated-orcid":false,"given":"Elena","family":"Biagini","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Policlinico S.Orsola-Malpighi , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariolina","family":"Lovecchio","sequence":"additional","affiliation":[{"name":"Boston Scientific , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9005-6021","authenticated-orcid":false,"given":"Rossella","family":"Baldini","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Clinical and Molecular Medicine, Sant\u2019Andrea Hospital , University Sapienza, Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-9911","authenticated-orcid":false,"given":"Giulio","family":"Falasconi","sequence":"additional","affiliation":[{"name":"Campus Cl\u00ednic, University of Barcelona , Barcelona , Spain"},{"name":"IRCCS Humanitas Research Hospital , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo","family":"Autore","sequence":"additional","affiliation":[{"name":"Cardiology, Department of Clinical and Molecular Medicine, Sant\u2019Andrea Hospital , University Sapienza, Rome , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4590-8584","authenticated-orcid":false,"given":"Mauro","family":"Biffi","sequence":"additional","affiliation":[{"name":"Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Policlinico S.Orsola-Malpighi , Bologna , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2035-5621","authenticated-orcid":false,"given":"Franco","family":"Cecchi","sequence":"additional","affiliation":[{"name":"Careggi University Hospital, University of Florence , Florence , Italy"},{"name":"Department of Cardiovascular, Neural and Metabolic Sciences, IRCCS, Istituto Auxologico Italiano, San Luca Hospital , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"2023091910004146700_euad270-B1","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"2023091910004146700_euad270-B2","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023091910004146700_euad270-B3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.21037\/acs.2017.07.05","article-title":"Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an updated systematic review and meta-analysis of outcomes and complications","volume":"6","author":"Wang","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"2023091910004146700_euad270-B4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCHEARTFAILURE.112.969626","article-title":"Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Schinkel","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2023091910004146700_euad270-B5","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2013.01.037","article-title":"Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy","volume":"61","author":"Maron","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023091910004146700_euad270-B6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005820","article-title":"Clinical course and quality of life in high-risk patients with hypertrophic cardiomyopathy and implantable cardioverter-defibrillators","volume":"11","author":"Maron","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023091910004146700_euad270-B7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study","volume":"70","author":"Boersma","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023091910004146700_euad270-B8","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacep.2017.07.017","article-title":"Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case\u2013control studies","volume":"3","author":"Basu-Ray","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"2023091910004146700_euad270-B9","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/eurheartj\/ehab921","article-title":"Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study","volume":"43","author":"Lambiase","year":"2022","journal-title":"Eur Heart J"},{"key":"2023091910004146700_euad270-B10","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/europace\/euw337","article-title":"The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?","volume":"19","author":"Botto","year":"2017","journal-title":"Europace"},{"key":"2023091910004146700_euad270-B11","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/europace\/euab309","article-title":"Implantable cardioverter-defibrillators for hypertrophic cardiomyopathy: The Times They Are a-Changin\u2019","volume":"24","author":"Francia","year":"2022","journal-title":"Europace"},{"key":"2023091910004146700_euad270-B12","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"2023091910004146700_euad270-B13","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2023091910004146700_euad270-B14","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.hrthm.2016.01.001","article-title":"Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts","volume":"13","author":"Lambiase","year":"2016","journal-title":"Heart Rhythm"},{"key":"2023091910004146700_euad270-B15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.hrthm.2022.01.013","article-title":"Subcutaneous versus transvenous implantable defibrillator in patients with hypertrophic cardiomyopathy","volume":"19","author":"Jankelson","year":"2022","journal-title":"Heart Rhythm"},{"key":"2023091910004146700_euad270-B16","first-page":"e783","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"2023091910004146700_euad270-B17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/europace\/eup431","article-title":"Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers","volume":"12","author":"Christiaans","year":"2010","journal-title":"Europace"},{"key":"2023091910004146700_euad270-B18","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/jce.14005","article-title":"Ventricular fibrillation undersensing due to air entrapment in a patient implanted with a subcutaneous cardioverter defibrillator","volume":"30","author":"Adduci","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023091910004146700_euad270-B19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10840-018-0326-2","article-title":"Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool","volume":"52","author":"Francia","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"key":"2023091910004146700_euad270-B20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jce.12714","article-title":"Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy","volume":"26","author":"Francia","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023091910004146700_euad270-B21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.hrthm.2015.09.007","article-title":"Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy","volume":"13","author":"Maurizi","year":"2016","journal-title":"Heart Rhythm"},{"key":"2023091910004146700_euad270-B22","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/jce.15081","article-title":"Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique","volume":"32","author":"Francia","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023091910004146700_euad270-B23","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1093\/europace\/euaa231","article-title":"Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study","volume":"22","author":"Francia","year":"2020","journal-title":"Europace"},{"key":"2023091910004146700_euad270-B24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/europace\/euad028","article-title":"Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case\u2013control study","volume":"25","author":"Botto","year":"2023","journal-title":"Europace"},{"key":"2023091910004146700_euad270-B25","doi-asserted-by":"crossref","first-page":"e010381","DOI":"10.1161\/CIRCEP.121.010381","article-title":"Safety of omitting defibrillation efficacy testing with subcutaneous defibrillators: a propensity-matched case\u2013control study","volume":"14","author":"Bianchi","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023091910004146700_euad270-B26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jce.13121","article-title":"Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy","volume":"28","author":"Francia","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023091910004146700_euad270-B27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"JAMA"},{"key":"2023091910004146700_euad270-B28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008123","article-title":"Long-term outcome in high-risk patients with hypertrophic cardiomyopathy after primary prevention defibrillator implants","volume":"13","author":"Rowin","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023091910004146700_euad270-B29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.hrthm.2020.02.008","article-title":"Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: an international multicenter study","volume":"17","author":"Nazer","year":"2020","journal-title":"Heart Rhythm"},{"key":"2023091910004146700_euad270-B30","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"key":"2023091910004146700_euad270-B31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N Engl J Med"},{"key":"2023091910004146700_euad270-B32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.hrthm.2015.01.017","article-title":"Low inappropriate shock rates in patients with single- and dual\/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results","volume":"12","author":"Auricchio","year":"2015","journal-title":"Heart Rhythm"},{"key":"2023091910004146700_euad270-B33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/pace.13665","article-title":"Safety and efficacy of anti-tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD","volume":"42","author":"Adduci","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"2023091910004146700_euad270-B34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jce.13194","article-title":"Ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy and defibrillators: triggers, treatment, and implications","volume":"28","author":"Link","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023091910004146700_euad270-B35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCULATIONAHA.121.057816","article-title":"Efficacy and safety of appropriate shocks and antitachycardia pacing in transvenous and subcutaneous implantable defibrillators: analysis of all appropriate therapy in the PRAETORIAN trial","volume":"145","author":"Knops","year":"2022","journal-title":"Circulation"},{"key":"2023091910004146700_euad270-B36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","article-title":"Primary results from the understanding outcomes with the S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) trial","volume":"143","author":"Gold","year":"2021","journal-title":"Circulation"},{"key":"2023091910004146700_euad270-B37","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euac234","article-title":"Reduction in inappropriate therapies through device programming in subcutaneous implantable defibrillator patients: data from clinical practice","volume":"25","author":"Rordorf","year":"2023","journal-title":"Europace"},{"key":"2023091910004146700_euad270-B38","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/europace\/euw415","article-title":"Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis","volume":"19","author":"Auricchio","year":"2017","journal-title":"Europace"},{"key":"2023091910004146700_euad270-B39","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/europace\/euac046","article-title":"Air entrapment as a potential cause of early subcutaneous implantable cardioverter defibrillator malfunction: a systematic review of the literature","volume":"24","author":"Ali","year":"2022","journal-title":"Europace"},{"key":"2023091910004146700_euad270-B40","doi-asserted-by":"crossref","DOI":"10.1007\/s10840-023-01468-1","article-title":"Incidence of premature battery depletion in subcutaneous cardioverter-defibrillator patients: insights from a multicenter registry","author":"L\u00fcker","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"2023091910004146700_euad270-B41","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.hrthm.2022.03.009","article-title":"Longevity of model 3501 subcutaneous implantable cardioverter-defibrillator leads in clinical practice","volume":"19","author":"Viani","year":"2022","journal-title":"Heart Rhythm"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/9\/euad270\/51677214\/euad270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/9\/euad270\/51677214\/euad270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T10:01:20Z","timestamp":1695117680000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad270\/7276855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad270","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,8,2]]},"article-number":"euad270"}}